Health Tech Capitol | Erik Greenfield
7
archive,paged,author,author-egreenfield,author-7,paged-8,author-paged-8,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Author: Erik Greenfield

WAUKESHA, Wis., September 12, 2019 – GE Healthcare today announced the Food and Drug Administration’s 510(k) clearance of Critical Care Suite, an industry-first collection of artificial intelligence (AI) algorithms embedded on a mobile X-ray device. Built in collaboration with UC San Francisco (UCSF), using GE...

Redox’s “Redox Gives,” a program to ensure that nonprofits and public health teams have the necessary access to data to fully empower their initiative, helped its first live recipient, the Wisconsin Women’s Health Foundation (WWHF), the company announced today. According to a release, WWHF went live with electronic...

Primorigen Biosciences has been acquired by Nucleus Biologics, a leader in precision cell culture, the company announced today. “The exceptionally strong fit of the Nucleus and Primorigen product portfolios provide a compelling value proposition for customers seeking more complete solutions for cell biology research and production,” Primorigen...

In the not-so-distant past, the preferred exit ramp for young health-tech companies in Wisconsin was to be purchased by a bigger firm in California or elsewhere. The planned acquisition of Genomic Health by Madison-based Exact Sciences Corp. has altered that pattern, with intriguing possibilities for the...

Madison-based cancer diagnostics company Exact Sciences Corp. said Monday it plans to acquire Redwood City, California-based Genomic Health in a $2.8 billion cash-and-stock deal. Exact Sciences produces Cologuard, a noninvasive, at-home screening test that detects the presence of colon cancer in stool samples. Genomic Health develops Oncotype IQ, a portfolio of genomic...